HLA-II基因与变应性鼻炎特异性免疫治疗疗效相关
结果显示部分HLA-II等位基因与鼻塞、鼻痒、眼痒等症状改善正相关或负相关,提示其可能作为预测AIT疗效的生物标志物。
要点
- HLA-DRB1和HLA-DQB1多态性与屋尘螨AIT疗效相关。
- DRB1*03:01、DRB1*04:06等位基因与鼻症状评分改善正相关。
- DRB1*07:01:01、DRB1*11:01与非花粉症状改善负相关。
核心结论
- HLA-DRB1和HLA-DQB1基因多态性与中国屋尘螨致敏变应性鼻炎患者的AIT疗效相关。
主要发现
- DRB1*04:06和DRB1*14:05与鼻塞、鼻痒、眼痒及日常活动改善正相关。
- DQB1*03:02:01和DQB1*05:03:01与鼻塞、鼻痒、眼痒、行为问题及鼻症状评分改善正相关。
- DRB1*03:01和DRB1*04:06与鼻症状评分改善正相关。
- DRB1*07:01:01和DRB1*11:01与非花粉症状、行为问题及鼻症状改善负相关。
关键数值与推荐
- DRB1*03:01、DRB1*04:06、DQB1*03:02:01和DQB1*05:03:01可能是预测AR患者AIT疗效的有用生物标志物。
临床怎么用
- HLA-II基因分型或可辅助筛选最可能从屋尘螨AIT获益的变应性鼻炎患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although the precise mechanisms underlying the efficacy of allergen-specific immunotherapy (AIT) are not clear, some evidence suggests that this may be linked to polymorphisms in HLA-II gene. We aimed to investigate the correlation between HLA-II gene polymorphisms and house dust mite (HDM)-specific immunotherapy efficacy, and evaluate specific polymorphisms as potential biomarkers in allergic rhinitis (AR) patients who would benefit most from AIT. METHODS: Fifty-one Han Chinese patients with AR receiving HDM AIT were recruited. Genomic DNA was extracted from venous blood samples and genotyped for HLA-DRB1 and HAL-DQB1 alleles using the polymerase chain reaction sequence-based genotyping method. Nasal and eye symptoms were investigated based on visual analogue scale and rhinoconjunctivitis quality of life. RESULTS: Allele DRB1*04:06; DRB1*14:05 showed a positive correlation with improvements in nasal blockage, nasal itching, eye itching, and activities. Similarly, DQB1*03:02:01; DQB1*05:03: 01 was positively correlated with improvements in nose blocking, nasal itching, eye itching, behavioral problems, and nasal symptoms scores; and DRB1*03:01; DRB1*04:06 positively correlated with nasal symptoms scores. In contrast, DRB1*07:01:01; DRB1*11:01 was negatively correlated with non-pollen symptoms, behavioral problems, and nasal symptoms. CONCLUSION: HLA-DRB1 and HLA-DQB1 gene polymorphism are associated with AIT efficacy in HDM-sensitive Chinese patients with AR, of which DRB1*03:01; DRB1*04:06 and DQB1*03:02:01; DQB1*05:03:01 may be useful biomarkers of AR patient candidacy for effective AIT.
引用
- Zhao Y, Zhao Y, Zhang Y, et al. HLA-II genes are associated with outcomes of specific immunotherapy for allergic rhinitis. Int Forum Allergy Rhinol. 2019. PMID: 31299142. doi:10.1002/alr.22384
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。